Editas Medicine, Inc. (EDIT) Shareholders’ equity 2016–2025
Editas Medicine, Inc. (EDIT) shareholders’ equity at each fiscal year-end, per SEC filings.
$27.3MFY2025 · since FY2016: $134.6M → $27.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $27.3M | -79.7% |
| FY2024 | $134.3M | -61.5% |
| FY2023 | $349.1M | -3.2% |
| FY2022 | $360.7M | -34.9% |
| FY2021 | $553.6M | +40.7% |
| FY2020 | $393.6M | +50.0% |
| FY2019 | $262.4M | +11.1% |
| FY2018 | $236.2M | +13.5% |
| FY2017 | $208.1M | +54.6% |
| FY2016 | $134.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice